ArticleClinical kidney journal2026

Impact of dapagliflozin on bone mineral metabolism in non-diabetic patients with chronic kidney disease: a randomized, double-blind, placebo-controlled study.

Mohamed Elshayeb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.